Graves' disease and hyperthyroidism trials in Netherlands
3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Dordrecht, Rotterdam
- Age
- 18 years to 75 years
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - Phase 1Taking peoplePhase 1 Single Ascending and Multiple Ascending Dose Study with LCA-0321
- Where
- Groningen, Rotterdam, 's-Hertogenbosch
- Age
- 18 years and over
- People
- 22
- Run by
- Lycia Therapeutics Inc.
See details and how to join2025-524053-14-00 - Phase 2Taking peopleA Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Where
- Dordrecht, Rotterdam
- Age
- 18 years and over
- People
- 128 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to join2025-524001-33-00